AUGUST 2024LIFE SCIENCES REVIEW5Marc de Garidel, Chief Executive Officer,AbivaxLeveraging Technological Advancements for Developing Innovative Therapeutics19Piero Rijli, Corporate Director, Regulatory Activities and Market Access, MENARINI GroupThe value of new antibiotics in the fight against AMR26Peter René Hesse, Vice President Head of Genomics Business, QIAGENUnlocking The Potential of Next-Generation Sequencing28CXO INSIGHTSMassimo Marzorati, CEO24ProDigestStefano Ferrara, Director, Clinical Science, BeiGeneWill AI affect my jobs and the CRO business?23TOP 10CROsIN EUROPE - 2024Paula Mendoza,CEOSon Guk Jin,CEOAnaPath Services1821Galileo Research
< Page 4 | Page 6 >